NUTRITIONAL GROWTH SOLUTIONS LTD — Director's Dealing 2022

Nov 20, 2022

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Nutritional Growth Solutions Ltd ARBN 642861774

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	David Fenlon
Date of last notice	6 October 2022

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.
Date of change	21 November 2022
No. of securities held prior to change	5,000,000 unlisted options exercisable at A$0.27 expiring 28/2/2027
Class	1. Fully paid ordinary shares 2. Listed options exercisable at $0.27 expiring 19/11/23 (Listed Options)
Number acquired	1. 250,000 fully paid ordinary shares 2. 125,000 Listed Options
Number disposed	Nil
Value/Consideration Note: If consideration is non‐cash, provide details and estimated valuation	$30,000
No. of securities held after change	1. 250,000 fully paid ordinary shares 2. 125,000 Listed Options

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

	3. 5,000,000 unlisted options exercisable at A$0.27
	expiring 28/2/2027
Nature of change	Issue of fully paid ordinary shares and Listed Options
Example: on‐market trade, off‐market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy‐back	following participation by Mr Fenlon in the Placement announced 22 August 2022 and approved at a meeting of shareholders held 17 November 2022.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non‐cash, provide details and an estimated valuation	N/A
Interest after change	N/A

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011